Aktienanalyse wird geladen …
MRSH · NYSE · Insurance Brokers · USA
169,89 $
| Geschäftsjahr | Umsatz | Nettogewinn | EPS (GAAP) | Aktien (verw., gesamt) | SBC in Stück | Rückkäufe (ca.) | Nettomarge | SBC / Aktie | Dividende / Aktie |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | 26,98 Mrd. | 4,16 Mrd. | 8,43 $ | 494 Mio. | 2,3 Mio · 0,5 % | 4,3 Mio · 0,9 % | 15,4 % | 0,80 $ | 3,43 $ |
| 2024 | 24,46 Mrd. | 4,06 Mrd. | 8,18 $ | 496 Mio. | 2,2 Mio · 0,4 % | 5,2 Mio · 1 % | 16,6 % | 0,74 $ | 3,05 $ |
| 2023 | 22,74 Mrd. | 3,76 Mrd. | 7,53 $ | 499 Mio. | 2,1 Mio · 0,4 % | 8,1 Mio · 1,6 % | 16,5 % | 0,73 $ | 2,60 $ |
| 2022 | 20,72 Mrd. | 3,05 Mrd. | 6,04 $ | 505 Mio. | 2,2 Mio · 0,4 % | 10,2 Mio · 2 % | 14,7 % | 0,73 $ | 2,25 $ |
| 2021 | 19,82 Mrd. | 3,14 Mrd. | 6,13 $ | 513 Mio. | 2 Mio · 0,4 % | 1 Mio · 0,2 % | 15,9 % | 0,68 $ | — |
| 2020 | 17,22 Mrd. | 2,02 Mrd. | 3,94 $ | 512 Mio. | 1,7 Mio · 0,3 % | 0,7 Mio · 0,1 % | 11,7 % | 0,57 $ | 1,84 $ |
| Quartal | Umsatz | Nettogewinn | EPS | Aktien (verw., gesamt) | Nettomarge |
|---|---|---|---|---|---|
| Q2 2026 | 7,4 Mrd. | 1,27 Mrd. | 2,63 $ | 482 Mio. | 17,1 % |
| Q1 2026 | 7,6 Mrd. | 1,15 Mrd. | 2,36 $ | 486 Mio. | 15,1 % |
| Q4 2025 | 6,6 Mrd. | 821 Mio. | 1,66 $ | 490 Mio. | 12,5 % |
| Q3 2025 | 6,35 Mrd. | 747 Mio. | 1,51 $ | 494 Mio. | 11,8 % |
| Q2 2025 | 6,97 Mrd. | 1,21 Mrd. | 2,45 $ | 495 Mio. | 17,4 % |
| Q1 2025 | 7,06 Mrd. | 1,38 Mrd. | 2,79 $ | 495 Mio. | 19,6 % |
| Q4 2024 | 6,07 Mrd. | 788 Mio. | 1,60 $ | — | 13 % |
| Q3 2024 | 5,7 Mrd. | 747 Mio. | 1,51 $ | 496 Mio. | 13,1 % |
Can Marsh Benefit From Changing Asset Owner Priorities?
Cash, infrastructure and emerging markets gain ground as large asset owners seek to manage volatility spikes, according to Marsh
Is Marsh & McLennan Stock Underperforming the S&P 500?
Marsh to Host Third Quarter Earnings Investor Call on October 15
Marsh & McLennan Companies, Inc. is a global professional services company focused on risk, strategy, and people. Marsh & McLennan Companies provides insurance broking, risk advisory, reinsurance and capital solutions, human capital consulting, health and wealth advice, and management and economic consulting through its core businesses: Marsh, Guy Carpenter, Mercer, and Oliver Wyman. The company serves businesses, public institutions, insurers, and other organizations that rely on specialized guidance in risk transfer, workforce planning, benefits, and organizational performance. Its services are widely used across industries to support insurance placement, reinsurance brokerage, employee benefits, retirement consulting, and strategic decision-making. Headquartered in New York, Marsh & McLennan Companies plays a significant role in the global market for professional services and insurance intermediation.
WebsiteMit einem Konto testest du Glancefield Pro 3 Tage gratis und bewertest MRSH und jede andere Aktie unbegrenzt.